Roche`s Fenebrutinib Shows Promise In Multiple Sclerosis
04 Sep 2024 //
GLOBENEWSWIRE
Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles
04 Sep 2024 //
BIOSPACE
Genentech MS drug on partial US hold on liver enzyme elevations
05 Dec 2023 //
FIERCE BIOTECH
Late-breaking data for Roche™s fenebrutinib show reduction in lesions
13 Oct 2023 //
GLOBENEWSWIRE
Roche says new MS drug shown to reduce brain lesions
18 May 2023 //
REUTERS
Genentech’s BTK Inhibitor Fenebrutinib Significantly Reduced Brain Lesions
17 May 2023 //
BUSINESSWIRE